$TAK

@jacobpliethDec 12, 2025 · 3:49 PM

$BMY sends $PFE $TAK Adcetris a shot across the bows. Via @ApexOnco -> https://t.co/JW2jzGpKHf

@jacobpliethDec 12, 2025 · 1:02 PM

Hands up who before yesterday had heard of the SWOG S1826 study... 8 Apr 2026 Pdufa date for $BMY Opdivo + chemo in 1L Hodgkin's where it beat $PFE $TAK Adcetris: 3yr PFS FU via Alex Herrera @ #ASH25 https://t.co/gKPGs5tTOx

@jacobpliethNov 19, 2025 · 4:33 PM

$IVBXF CFO Rachel You reckons this is where everyone else went wrong in IL-2 #Jefferies25 $TAK

@jacobpliethOct 22, 2025 · 3:01 PM

$IVBXF perseveres with IL-2 cytokine and scores a big deal at last. Some disappointment that this is with $TAK and not a big pharma player? Via @ApexOnco -> https://t.co/U7G0JxKSkn

@jacobpliethOct 22, 2025 · 11:32 AM

Pretty amazing run-up by $IVBXF - +135% YTD or +40% since #ASCO25 on the back of IBI363. Does today's $1.2bn up front from $TAK justify the enthusiasm?

@jacobpliethOct 2, 2025 · 1:01 PM

It's cellexit! $TAK

@jacobpliethOct 1, 2025 · 6:58 PM

@jq1234t @ByMadeleineA And guess what the carrying value of $TAK Gammadelta was (not sure the acquisition price had ever been disclosed) https://t.co/ESUJMzrJQC

@jacobpliethOct 1, 2025 · 4:24 PM

So apparently it's all over for $TAK in cell therapy https://t.co/fVcLcSn0gG https://t.co/Sv24FmgVZ6

@jacobpliethSep 15, 2025 · 8:39 AM

My earlier take on this and other ADCs that use Sting agonist payloads, from July: https://t.co/B879yVppH0 $DSNKY $ESALY $EXEL $MKGAF $TAK $MRSN $GSK

@adamfeuersteinSep 8, 2025 · 9:41 AM

$ALKS $TAK orexin data presentations from the sleep meeting in Singapore. Alkermes, Takeda show encouraging data on narcolepsy drugs https://t.co/TJtEk9EgeB via @elaineywchen

@adamfeuersteinJul 22, 2025 · 12:19 PM

Drugmakers are racing to help patients stay awake — and could also make billions A great read from my colleague @elaineywchen reporting on the development of orexin inhibitors $ALKS $CNTA $TAK Link below...